GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYRY) » Definitions » Float Percentage Of Total Shares Outstanding

Bayer AG (Bayer AG) Float Percentage Of Total Shares Outstanding : 0.00% (As of Apr. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Bayer AG Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bayer AG's float shares is 0.00 Mil. Bayer AG's total shares outstanding is 3,929.70 Mil. Bayer AG's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bayer AG's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bayer AG's Institutional Ownership is 0.44%.


Bayer AG Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Bayer AG's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/3,929.70
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bayer AG (Bayer AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYRY) » Definitions » Float Percentage Of Total Shares Outstanding
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.